Clinical Trial Update: Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating long-acting cabotegravir injectable as pre-exposure prophylaxis for HIV in people who inject drugs; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Substance Use Disorder

Drugs mentioned

• Apretude (cabotegravir) (cabotegravir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV, Substance Use Disorder (SUD) | Phase 4 | Status: RECRUITING